Couldnt agree more Goldilocks. Strikerboy is kidding himself. The companies focus on nickel as apposed to io was not only due to nickels bullish outlook at the time Wowos exploration began but Argyle wasnt deemed to be of significant importance.
Strikerboy, do you really think that with the future forecasting of io RMI would try and sell an io tenement if they rated it? Of course they wouldnt. Its worth very little.
Lets be realistic here and accept RMI has only $500k on hand and the wowo project as its only valuable assets. If wowos tenement renewal is approved then it will have a positive short term affect on the sp but further share dilution is inevitable.
I will hold but I prefer reading honest a realistic company assesments. Wowo is a world class nickel deposit but the chances the project gets off the ground are extremely low. If however a pre-feas can be funded and a JV partner found with minimal share dilution we could possibly make some serious gains. I still believe its worth the "wait and see" approach but will never ramp this stock and wish others wouldnt.
Cheers ant
- Forums
- ASX - By Stock
- RMI
- starting to run
starting to run, page-21
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.566M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $294 | 42.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1306850 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 38461 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1306850 | 0.006 |
2 | 600000 | 0.005 |
2 | 688888 | 0.004 |
1 | 700000 | 0.003 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 38461 | 1 |
0.008 | 757827 | 2 |
0.009 | 658961 | 3 |
0.010 | 15000 | 1 |
0.011 | 688499 | 1 |
Last trade - 11.08am 12/11/2024 (20 minute delay) ? |
Featured News
RMI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online